Cite
Study of γ-glutamyltranspeptidase as a prognostic marker in radiofrequency: Ablation treatment of hepatocellular carcinoma
MLA
Mohamed A Nouh, et al. “Study of γ-Glutamyltranspeptidase as a Prognostic Marker in Radiofrequency: Ablation Treatment of Hepatocellular Carcinoma.” Menoufia Medical Journal, vol. 30, Jan. 2017, p. 1220. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........b2dfd406faf0825d6df0f7f226ba23b9&authtype=sso&custid=ns315887.
APA
Mohamed A Nouh, Basma Mohiy Eissa, & Eman M Abd El-Gayed. (2017). Study of γ-glutamyltranspeptidase as a prognostic marker in radiofrequency: Ablation treatment of hepatocellular carcinoma. Menoufia Medical Journal, 30, 1220.
Chicago
Mohamed A Nouh, Basma Mohiy Eissa, and Eman M Abd El-Gayed. 2017. “Study of γ-Glutamyltranspeptidase as a Prognostic Marker in Radiofrequency: Ablation Treatment of Hepatocellular Carcinoma.” Menoufia Medical Journal 30 (January): 1220. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........b2dfd406faf0825d6df0f7f226ba23b9&authtype=sso&custid=ns315887.